The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment
Abstract
Chronic inflammation and immune responses are two core element that characterize the tumor microenvironment. A large number of immune/inflammatory cells (including tumor associated macrophages, neutrophils and myeloid derived suppressor cells) as well as cytokines (such as IL-6, IL-10, TGF-β) are present in the tumor microenvironment, which results in both a chronic inflammatory state and immunosuppression. As a consequence tumor cell migration, invasion, metastasis and anticancer drug sensitivity are modulated. On the one hand, secreted cytokines change the function of cytotoxic T lymphocytes and antigen presenting cells, thereby inhibiting tumor specific immune responses and consequently inducing a special immunosuppressive microenvironment for tumor cells. On the other hand, tumor cells change the differentiation and function of immune/inflammatory cells in the tumor microenvironment especially via the NF-κB and STAT3 signaling pathways. This may promote proliferation of tumor cells. Here we review these double edged effects of immune/inflammatory cells and cytokines on tumor cells, and explored their interactions with inflammation, hypoxia, and immune responses in the tumor microenvironment. The tumor inflammatory or immunosuppressive reactions mediated by the high activity of NF-κB or STAT3 can occur alone or simultaneously, and there is a certain connection between them. Inhibiting the NF-κB or STAT3 signaling pathway is likely to curb the growth of tumor cells, reduce the secretion of pro-inflammatory factors, and enhance the anti-tumor immune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED: FoxP3 Acts as a Cotranscription Factor with STAT3 in Tumor-Induced Regulatory T Cells
Hossain, D. M. S., Panda, A. K., Manna, A., Mohanty, S., Bhattacharjee, P., Bhattacharyya, S., Saha, T., Chakraborty, S., Kar, R. K., Das, T., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.11.005 · Cited by 116
RetractedGuo, J., Kim, D., Gao, J., Kurtyka, C. A., Chen, H., Yu, C., Wu, D., Mittal, A., Beg, A. A., Chellappan, S., et al. (2012) · Oncogene · doi:10.1038/onc.2012.39 · Cited by 77
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
IL‐6 in inflammation, immunity, and disease
Tanaka, T., Narazaki, M., & Kishimoto, T. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016295 · Cited by 5,046
Macrophages in Tissue Repair, Regeneration, and Fibrosis
Wynn, T. A., & Vannella, K. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.015 · Cited by 4,481
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
The regulation of IL-10 production by immune cells
Saraiva, M., & O'Garra, A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2711 · Cited by 3,164
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Johnson, D. E., O'Keefe, R. A., & Grandis, J. R. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.8 · Cited by 3,110
The Three Es of Cancer Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104803 · Cited by 3,072
NF-κB, inflammation, immunity and cancer: coming of age
Taniguchi, K., & Karin, M. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.142 · Cited by 2,679
Macrophages as regulators of tumour immunity and immunotherapy
DeNardo, D. G., & Ruffell, B. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0127-6 · Cited by 2,528
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Kumar, V., Patel, S., Tcyganov, E., & Gabrilovich, D. I. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.01.004 · Cited by 2,008
Macrophages and Therapeutic Resistance in Cancer
Ruffell, B., & Coussens, L. M. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.015 · Cited by 1,474
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
Solinas, G., Germano, G., Mantovani, A., & Allavena, P. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0609385 · Cited by 1,425
Corzo, C. A., Condamine, T., Lu, L., Cotter, M. J., Youn, J.-I., Cheng, P., Cho, H.-I., Celis, E., Quiceno, D. G., Padhya, T., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100587 · Cited by 1,173
PI3Kγ is a molecular switch that controls immune suppression
Kaneda, M. M., Messer, K. S., Ralainirina, N., Li, H., Leem, C. J., Gorjestani, S., Woo, G., Nguyen, A. V., Figueiredo, C. C., Foubert, P., et al. (2016) · Nature · doi:10.1038/nature19834 · Cited by 1,173
Ruffell, B., Chang-Strachan, D., Chan, V., Rosenbusch, A., Ho, C. M. T., Pryer, N., Daniel, D., Hwang, E. S., Rugo, H. S., & Coussens, L. M. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.006 · Cited by 1,008
Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines
Schauer, C., Janko, C., Munoz, L. E., Zhao, Y., Kienhöfer, D., Frey, B., Lell, M., Manger, B., Rech, J., Naschberger, E., et al. (2014) · Nature Medicine · doi:10.1038/nm.3547 · Cited by 998
Self-citationChaudhry, A., Samstein, R. M., Treuting, P., Liang, Y., Pils, M. C., Heinrich, J.-M., Jack, R. S., Wunderlich, F. T., Brüning, J. C., Müller, W., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.018 · Cited by 980
Cheng, P., Corzo, C. A., Luetteke, N., Yu, B., Nagaraj, S., Bui, M. M., Ortiz, M., Nacken, W., Sorg, C., Vogl, T., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080132 · Cited by 902
Zhou, S.-L., Zhou, Z.-J., Hu, Z.-Q., Huang, X.-W., Wang, Z., Chen, E.-B., Fan, J., Cao, Y., Dai, Z., & Zhou, J. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.040 · Cited by 852
Iliopoulos, D., Jaeger, S. A., Hirsch, H. A., Bulyk, M. L., & Struhl, K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.07.023 · Cited by 830
A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1
Pillay, J., Kamp, V. M., van Hoffen, E., Visser, T., Tak, T., Lammers, J.-W., Ulfman, L. H., Leenen, L. P., Pickkers, P., & Koenderman, L. (2012) · Journal of Clinical Investigation · doi:10.1172/jci57990 · Cited by 828
Teijeira, Á., Garasa, S., Gato, M., Alfaro, C., Migueliz, I., Cirella, A., de Andrea, C., Ochoa, M. C., Otano, I., Etxeberria, I., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.03.001 · Cited by 788
Neutrophil plasticity in the tumor microenvironment
Giese, M. A., Hind, L. E., & Huttenlocher, A. (2019) · Blood · doi:10.1182/blood-2018-11-844548 · Cited by 783
Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells
Corzo, C. A., Cotter, M. J., Cheng, P., Cheng, F., Kusmartsev, S., Sotomayor, E., Padhya, T., McCaffrey, T. V., McCaffrey, J. C., & Gabrilovich, D. I. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900092 · Cited by 763
TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis
Xu, F., Liu, C., Zhou, D., & Zhang, L. (2016) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155415627681 · Cited by 756
Puga, I., Cols, M., Barra, C. M., He, B., Cassis, L., Gentile, M., Comerma, L., Chorny, A., Shan, M., Xu, W., et al. (2012) · Nature Immunology · doi:10.1038/ni.2194 · Cited by 727
Doedens, A. L., Stockmann, C., Rubinstein, M. P., Liao, D., Zhang, N., DeNardo, D. G., Coussens, L. M., Karin, M., Goldrath, A. W., & Johnson, R. S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1439 · Cited by 652
Takeda, N., O'Dea, E. L., Doedens, A., Kim, J.-W., Weidemann, A., Stockmann, C., Asagiri, M., Simon, M. C., Hoffmann, A., & Johnson, R. S. (2010) · Genes & Development · doi:10.1101/gad.1881410 · Cited by 623
Targeting the TGFβ pathway for cancer therapy
Neuzillet, C., Tijeras-Raballand, A., Cohen, R., Cros, J., Faivre, S., Raymond, E., & de Gramont, A. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.001 · Cited by 611
GM-CSF: From Growth Factor to Central Mediator of Tissue Inflammation
Becher, B., Tugues, S., & Greter, M. (2016) · Immunity · doi:10.1016/j.immuni.2016.10.026 · Cited by 593
Shouval, D. S., Biswas, A., Goettel, J. A., McCann, K., Conaway, E., Redhu, N. S., Mascanfroni, I. D., Al Adham, Z., Lavoie, S., Ibourk, M., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.03.011 · Cited by 584
Coccia, M., Harrison, O. J., Schiering, C., Asquith, M. J., Becher, B., Powrie, F., & Maloy, K. J. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111453 · Cited by 580
Neutrophils in the tumor microenvironment
Powell, D. R., & Huttenlocher, A. (2016) · Trends in Immunology · doi:10.1016/j.it.2015.11.008 · Cited by 578
SOCS3, a Major Regulator of Infection and Inflammation
Carow, B., & Rottenberg, M. E. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00058 · Cited by 555
TGF- : Duality of Function Between Tumor Prevention and Carcinogenesis
Principe, D. R., Doll, J. A., Bauer, J., Jung, B., Munshi, H. G., Bartholin, L., Pasche, B., Lee, C., & Grippo, P. J. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt369 · Cited by 523
Therapeutically exploiting STAT3 activity in cancer — using tissue repair as a road map
Huynh, J., Chand, A., Gough, D., & Ernst, M. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-018-0090-8 · Cited by 504
Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum
Lee, W., Ko, S. Y., Mohamed, M. S., Kenny, H. A., Lengyel, E., & Naora, H. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20181170 · Cited by 478
Pathways connecting inflammation and cancer
Allavena, P., Garlanda, C., Borrello, M. G., Sica, A., & Mantovani, A. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.01.003 · Cited by 437
The IL-10/STAT3-mediated anti-inflammatory response: recent developments and future challenges
Hutchins, A. P., Diez, D., & Miranda-Saavedra, D. (2013) · Briefings in Functional Genomics · doi:10.1093/bfgp/elt028 · Cited by 415
The roles of tumor-associated macrophages in tumor angiogenesis and metastasis
Fu, L.-Q., Du, W.-L., Cai, M.-H., Yao, J.-Y., Zhao, Y.-Y., & Mou, X.-Z. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104119 · Cited by 415
Self-citationHartman, Z. C., Poage, G. M., den Hollander, P., Tsimelzon, A., Hill, J., Panupinthu, N., Zhang, Y., Mazumdar, A., Hilsenbeck, S. G., Mills, G. B., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4524-t · Cited by 409
Noman, M. Z., Hasmim, M., Messai, Y., Terry, S., Kieda, C., Janji, B., & Chouaib, S. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00207.2015 · Cited by 400
Albini, A., Bruno, A., Noonan, D. M., & Mortara, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00527 · Cited by 392
The dynamic roles of TGF‐β in cancer
Meulmeester, E., & ten Dijke, P. (2011) · The Journal of Pathology · doi:10.1002/path.2785 · Cited by 388
Poschke, I., Mougiakakos, D., Hansson, J., Masucci, G. V., & Kiessling, R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3767 · Cited by 382
Jiang, G.-M., Tan, Y., Wang, H., Peng, L., Chen, H.-T., Meng, X.-J., Li, L.-L., Liu, Y., Li, W.-F., & Shan, H. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0944-z · Cited by 365
Self-citationMeyer, C., Sevko, A., Ramacher, M., Bazhin, A. V., Falk, C. S., Osen, W., Borrello, I., Kato, M., Schadendorf, D., Baniyash, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108121108 · Cited by 346
Qian, M., Wang, S., Guo, X., Wang, J., Zhang, Z., Qiu, W., Gao, X., Chen, Z., Xu, J., Zhao, R., et al. (2020) · Oncogene · doi:10.1038/s41388-019-0996-y · Cited by 345
Self-citationChow, A., Zhou, W., Liu, L., Fong, M. Y., Champer, J., Van Haute, D., Chin, A. R., Ren, X., Gugiu, B. G., Meng, Z., et al. (2014) · Scientific Reports · doi:10.1038/srep05750 · Cited by 345
Rébé, C., & Ghiringhelli, F. (2020) · Cancers · doi:10.3390/cancers12071791 · Cited by 337
Exosomal noncoding RNAs in Glioma: biological functions and potential clinical applications
Cheng, J., Meng, J., Zhu, L., & Peng, Y. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01189-3 · Cited by 319
LIU, R.-Y., ZENG, Y., LEI, Z., WANG, L., YANG, H., LIU, Z., ZHAO, J., & ZHANG, H.-T. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2310 · Cited by 308
Mouse and human neutrophils induce anaphylaxis
Jönsson, F., Mancardi, D. A., Kita, Y., Karasuyama, H., Iannascoli, B., Van Rooijen, N., Shimizu, T., Daëron, M., & Bruhns, P. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45232 · Cited by 306
De Santo, C., Arscott, R., Booth, S., Karydis, I., Jones, M., Asher, R., Salio, M., Middleton, M., & Cerundolo, V. (2010) · Nature Immunology · doi:10.1038/ni.1942 · Cited by 304
Deryugina, E. I., Zajac, E., Juncker-Jensen, A., Kupriyanova, T. A., Welter, L., & Quigley, J. P. (2014) · Neoplasia · doi:10.1016/j.neo.2014.08.013 · Cited by 304
Li, S., Cong, X., Gao, H., Lan, X., Li, Z., Wang, W., Song, S., Wang, Y., Li, C., Zhang, H., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-1003-0 · Cited by 299
Self-citationAn Attempt to Polarize Human Neutrophils Toward N1 and N2 Phenotypes in vitro
Ohms, M., Möller, S., & Laskay, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00532 · Cited by 299
Interplay between inflammation and cancer
(2020) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/bs.apcsb.2019.09.004 · Cited by 290
IL-10 Potentiates Differentiation of Human Induced Regulatory T Cells via STAT3 and Foxo1
Hsu, P., Santner-Nanan, B., Hu, M., Skarratt, K., Lee, C. H., Stormon, M., Wong, M., Fuller, S. J., & Nanan, R. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402898 · Cited by 286
Tang, L.-Y., Heller, M., Meng, Z., Yu, L.-R., Tang, Y., Zhou, M., & Zhang, Y. E. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.773085 · Cited by 278
Asiedu, M. K., Ingle, J. N., Behrens, M. D., Radisky, D. C., & Knutson, K. L. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4554 · Cited by 270
Fibrosis Related Inflammatory Mediators: Role of the IL‐10 Cytokine Family
Sziksz, E., Pap, D., Lippai, R., Béres, N. J., Fekete, A., Szabó, A. J., & Vannay, Á. (2015) · Mediators of Inflammation · doi:10.1155/2015/764641 · Cited by 265
Mishalian, I., Bayuh, R., Eruslanov, E., Michaeli, J., Levy, L., Zolotarov, L., Singhal, S., Albelda, S. M., Granot, Z., & Fridlender, Z. G. (2014) · International Journal of Cancer · doi:10.1002/ijc.28770 · Cited by 253
Nie, M., Yang, L., Bi, X., Wang, Y., Sun, P., Yang, H., Liu, P., Li, Z., Xia, Y., & Jiang, W. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1226 · Cited by 250
Tumor Microenvironment and the Response to Anticancer Therapy
Brown, J. M. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.1.5.157 · Cited by 232
Zhou, S., Yin, D., Hu, Z., Luo, C., Zhou, Z., Xin, H., Yang, X., Shi, Y., Wang, Z., Huang, X., et al. (2019) · Hepatology · doi:10.1002/hep.30630 · Cited by 226
Cassetta, L., Baekkevold, E. S., Brandau, S., Bujko, A., Cassatella, M. A., Dorhoi, A., Krieg, C., Lin, A., Loré, K., Marini, O., et al. (2019) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-019-02302-2 · Cited by 224
Li, B.-H., Garstka, M. A., & Li, Z.-F. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2019.11.014 · Cited by 220
Maier, H. J., Schmidt-Straßburger, U., Huber, M. A., Wiedemann, E. M., Beug, H., & Wirth, T. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.03.003 · Cited by 215
Wang, Y., Yin, K., Tian, J., Xia, X., Ma, J., Tang, X., Xu, H., & Wang, S. (2019) · Advanced Science · doi:10.1002/advs.201901278 · Cited by 211
TGF-β-induced epithelial-mesenchymal transition: A link between cancer and inflammation
Fuxe, J., & Karlsson, M. C. I. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.05.004 · Cited by 198
Yang, C., He, L., He, P., Liu, Y., Wang, W., He, Y., Du, Y., & Gao, F. (2015) · Medical Oncology · doi:10.1007/s12032-014-0352-6 · Cited by 189
Breast Cancer-Derived Exosomes Alter Macrophage Polarization via gp130/STAT3 Signaling
Ham, S., Lima, L. G., Chai, E. P. Z., Muller, A., Lobb, R. J., Krumeich, S., Wen, S. W., Wiegmans, A. P., & Möller, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00871 · Cited by 189
Trovato, R., Fiore, A., Sartori, S., Canè, S., Giugno, R., Cascione, L., Paiella, S., Salvia, R., De Sanctis, F., Poffe, O., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0734-6 · Cited by 189
Interplay between inflammation and cancer
Piotrowski, I., Kulcenty, K., & Suchorska, W. (2020) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/j.rpor.2020.04.004 · Cited by 187
Targeting microRNAs as key modulators of tumor immune response
Paladini, L., Fabris, L., Bottai, G., Raschioni, C., Calin, G. A., & Santarpia, L. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0375-2 · Cited by 184
Li, T.-J., Jiang, Y.-M., Hu, Y.-F., Huang, L., Yu, J., Zhao, L.-Y., Deng, H.-J., Mou, T.-Y., Liu, H., Yang, Y., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0617 · Cited by 179
Xu, X., Zhang, L., He, X., Zhang, P., Sun, C., Xu, X., Lu, Y., & Li, F. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.05.139 · Cited by 175
Hwang, W.-L., Lan, H.-Y., Cheng, W.-C., Huang, S.-C., & Yang, M.-H. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0699-4 · Cited by 175
Inhibition of Rspo-Lgr4 Facilitates Checkpoint Blockade Therapy by Switching Macrophage Polarization
Tan, B., Shi, X., Zhang, J., Qin, J., Zhang, N., Ren, H., Qian, M., Siwko, S., Carmon, K., Liu, Q., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0152 · Cited by 165
Dual role of inflammatory mediators in cancer
Shrihari, T. (2017) · ecancermedicalscience · doi:10.3332/ecancer.2017.721 · Cited by 164
PGE2-Driven Induction and Maintenance of Cancer-Associated Myeloid-Derived Suppressor Cells
Obermajer, N., Wong, J. L., Edwards, R. P., Odunsi, K. O., Moysich, K. B., & Kaliński, P. (2012) · Immunological Investigations · doi:10.3109/08820139.2012.695417 · Cited by 148
Xi, X., Liu, N., Wang, Q., Chu, Y., Yin, Z., Ding, Y., & Lu, Y. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1986-2 · Cited by 147
Self-citationRegulation of Macrophage Arginase Expression and Tumor Growth by the Ron Receptor Tyrosine Kinase
Sharda, D. R., Yu, S., Ray, M., Squadrito, M. L., Palma, M. D., Wynn, T. A., Morris, S. M., & Hankey, P. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003460 · Cited by 144
Fleming, V., Hu, X., Weller, C., Weber, R., Groth, C., Riester, Z., Hüser, L., Sun, Q., Nagibin, V. S., Kirschning, C. J., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0053 · Cited by 142
Interleukins 1 and 6 as main mediators of inflammation and cancer
Dmitrieva, O., Shilovskiy, I. P., Khaitov, M. R., & Grivennikov, S. I. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916020024 · Cited by 141
Role of immune cells in pancreatic cancer from bench to clinical application: An updated review
Chang, J. H., Jiang, Y., & Pillarisetty, V. G. (2016) · Medicine · doi:10.1097/md.0000000000005541 · Cited by 137
Lin, Y., Yang, X., Liu, W., Li, B., Yin, W., Shi, Y., & He, R. (2017) · Oncogene · doi:10.1038/onc.2016.516 · Cited by 136
Neutrophils induce macrophage anti-inflammatory reprogramming by suppressing NF-κB activation
Marwick, J. A., Mills, R., Kay, O., Michail, K., Stephen, J., Rossi, A. G., Dransfield, I., & Hirani, N. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0710-y · Cited by 136
Epigenetic remodelling shapes inflammatory renal cancer and neutrophil-dependent metastasis
Nishida, J., Momoi, Y., Miyakuni, K., Tamura, Y., Takahashi, K., Koinuma, D., Miyazono, K., & Ehata, S. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0491-2 · Cited by 135
IKKβ in intestinal mesenchymal cells promotes initiation of colitis-associated cancer
Koliaraki, V., Pasparakis, M., & Kollias, G. A. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20150542 · Cited by 134
Bertrán, E., Crosas‐Molist, E., Sancho, P., Caja, L., López‐Luque, J., Navarro, E., Egea, G., Lastra, R., Serrano, T., Ramos, E., et al. (2013) · Hepatology · doi:10.1002/hep.26597 · Cited by 129
Jones, L., Broz, M. L., Ranger, J. J., Ozcelik, J., Ahn, R., Zuo, D., Ursini‐Siegel, J., Hallett, M. T., Krummel, M. F., & Muller, W. J. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2770 · Cited by 123
Di Conza, G., Trusso Cafarello, S., Loroch, S., Mennerich, D., Deschoemaeker, S., Di Matteo, M., Ehling, M., Gevaert, K., Prenen, H., Zahedi, R. P., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.01.051 · Cited by 119
Liu, Q., Tong, D., Liu, G., Xu, J., Do, K., Geary, K. R., Zhang, D., Zhang, J., Zhang, Y., Li, Y., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.417 · Cited by 115
Giallongo, C., Tibullo, D., Parrinello, N. L., Cava, P. L., Rosa, M. D., Bramanti, V., Raimondo, C. D., Conticello, C., Chiarenza, A., Palumbo, G. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7969 · Cited by 105
Geis-Asteggiante, L., Belew, A. T., Clements, V. K., Edwards, N. J., Ostrand-Rosenberg, S., El-Sayed, N. M., & Fenselau, C. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00646 · Cited by 104
Binsfeld, M., Muller, J., Lamour, V., Veirman, K. D., Raeve, H. D., Bellahcène, A., Valckenborgh, E. V., Baron, F., Beguin, Y. P., Caers, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9270 · Cited by 96
Cho, U., Kim, B., Kim, S., Han, Y., & Song, Y. S. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22750 · Cited by 94
Kuo, W.-Y., Hwu, L., Wu, C.-Y., Lee, J.-S., Chang, C., & Liu, R.-S. (2017) · Theranostics · doi:10.7150/thno.16827 · Cited by 92
Lopez‐Bergami, P., & Barbero, G. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09878-7 · Cited by 90
Zhang, X., Li, N., Shao, H., Meng, Y., Wang, L., Wu, Q., Yao, Y., Li, J., Bian, J., Zhang, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep29359 · Cited by 89
Li, L., Li, Y., Wang, L., Wang, F., Zhang, Z., Li, J., Yue, D., Chen, X., Yü, P., Huang, L. J., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30289 · Cited by 89
Self-citationAcquisition of Antigen-Presenting Functions by Neutrophils Isolated from Mice with Chronic Colitis
Ostanin, D. V., Kurmaeva, E., Furr, K., Bao, R., Hoffman, J. M., Berney, S. M., & Grisham, M. B. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102296 · Cited by 88
Liu, Y., Liu, L., Zhou, Y., Zhou, P., Yan, Q., Chen, X., Ding, S., & Zhu, F. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3510 · Cited by 81
Ohno, Y., Toyoshima, Y., Yurino, H., Monma, N., Xiang, H., Sumida, K., Kaneumi, S., Terada, S., Hashimoto, S., Ikeo, K., et al. (2017) · Cancer Science · doi:10.1111/cas.13330 · Cited by 80
Targeting IL-10 in Auto-immune Diseases
Tian, G., Li, J., Wang, D., & Zhou, D. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-9903-x · Cited by 79
Circulating Tumor Cell-Neutrophil Tango along the Metastatic Process
Saini, M., Szczerba, B. M., & Aceto, N. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1972 · Cited by 77
Wang, D., Yu, W., Lian, J., Wu, Q., Liu, S., Yang, L., Li, F., Huang, L. J., Chen, X., Zhang, Z., et al. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00897-z · Cited by 77
Multiple myeloma induces Mcl-1 expression and survival of myeloid-derived suppressor cells
Veirman, K. D., Ginderachter, J. A. V., Lub, S., Beule, N. D., Thielemans, K., Bautmans, I., Oyajobi, B. O., Bruyne, E. D., Menu, E., Lemaire, M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3300 · Cited by 70
Sun, X., Sui, Q., Zhang, C., Tian, Z., & Zhang, J. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1087 · Cited by 67
Interleukin‐6 contributes to chemoresistance in MDA‐MB‐231 cells via targeting HIF‐1α
Wang, K., Zhu, X., Zhang, K., Yin, Y., Chen, Y., & Zhang, T. (2018) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22039 · Cited by 61
Overcoming immunotherapeutic resistance by targeting the cancer inflammation cycle
Wattenberg, M. M., & Beatty, G. L. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.01.002 · Cited by 58
Recent advances in the study of regulatory T cells in gastric cancer
Liu, X., Zhang, Z., & Zhao, G. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.05.009 · Cited by 52
Choi, J., Sun, E. G., & Cho, S. (2019) · Chonnam Medical Journal · doi:10.4068/cmj.2019.55.1.31 · Cited by 51
IL-27: a double agent in the IL-6 family
Jones, G. W., Hill, D. G., Figueras, A. C., & Jones, S. A. (2018) · Clinical & Experimental Immunology · doi:10.1111/cei.13116 · Cited by 49
Wang, A., Zhang, F., Xu, H., Xu, M., Cao, Y. W., Wang, C., Xu, Y., Su, M., Zhang, M., & Zhuge, Y. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.04.003 · Cited by 47
Chang, W. H., Forde, D., & Lai, A. G. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1775-9 · Cited by 47
Xi, X., Liu, N., Wang, Q., Wu, H., He, H., Wang, L., Zhang, T.-J., Sun, L. T., Yin, Z. Q., Chen, Y., et al. (2018) · Journal of Chromatography B · doi:10.1016/j.jchromb.2018.11.004 · Cited by 47
Self-citationYue, D., Zhang, Z., Li, J., Chen, X., Yü, P., Liu, S., Shi, X., Li, L., Wang, L., Huang, L. J., et al. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.06.007 · Cited by 46
Self-citationDown-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer
Li, S., Tian, J., Zhang, H., et al. (2018) · APOPTOSIS · doi:10.1007/s10495-018-1460-0 · Cited by 46
Plasma Proteome Profiles Associated with Inflammation, Angiogenesis, and Cancer
Kelly‐Spratt, K. S., Pitteri, S. J., Gurley, K. E., Liggitt, D., Chin, A. P., Kennedy, J. J., Wong, C., Zhang, Q. H., Buson, T. B., Wang, H., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019721 · Cited by 43
Sasaki, S., Baba, T., Muranaka, H., Tanabe, Y., Takahashi, C., Matsugo, S., & Mukaida, N. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0845 · Cited by 43
Sun, H., Kuk, W., Rivera–Nieves, J., Lopez‐Ramirez, M. A., Eckmann, L., & Ginsberg, M. H. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.10.012 · Cited by 43
Yamanaka, S., Sato, Y., Oikawa, D., Gotō, E., Fukai, S., Tokunaga, F., Takahashi, H., & Sawasaki, T. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.12.049 · Cited by 42
Kim, N., & Kim, Y. (2018) · Cancer Medicine · doi:10.1002/cam4.1878 · Cited by 40
Ke, Z., Wang, C., Wu, T., Wang, W., Yang, Y., & Dai, Y. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.11.015 · Cited by 40
Inflammatory pathway interactions and cancer multidrug resistance regulation
Mirzaei, S. A., Dinmohammadi, F., Alizadeh, A., & Elahian, F. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116825 · Cited by 39
Crosstalk between myeloid-derived suppressor cells and the immune system in prostate cancer
Sanaei, M., Salimzadeh, L., & Bagheri, N. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.4ru0819-150rr · Cited by 38
Wang, L., Niu, Z., Wang, X., Li, Z., Liu, Y., Luo, F., & Yan, X. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117167 · Cited by 35
NDRG2-mediated Modulation of SOCS3 and STAT3 Activity Inhibits IL-10 Production
Lee, E. B., Kim, A., Kang, K., Kim, H., & Lim, J. (2010) · Immune Network · doi:10.4110/in.2010.10.6.219 · Cited by 33
TLR4 in skin cancer: From molecular mechanisms to clinical interventions
Dickinson, S. E., & Wondrak, G. T. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.23016 · Cited by 33
Qiao, J., Chen, Y., Mi, Y., Jin, H., Wang, L., Huang, T., Li, H., Song, Y., Cao, J., Wu, B., et al. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114126 · Cited by 28
Self-citationLiu, Y., Wang, L., Liu, J., Xie, X., Hu, H., & Luo, F. (2020) · Cancer Management and Research · doi:10.2147/cmar.s244748 · Cited by 25
Role of IL‐6‐mediated expression of NS5ATP9 in autophagy of liver cancer cells
Lu, H., Han, M., Yuan, X., Tursun, K., Zhang, Y., Li, Y., Li, Z., Feng, S., Zhou, L., Pan, Z., et al. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26343 · Cited by 24
Self-citationLi, H., Chen, A., Yuan, Q., Chen, W., Zhong, H., Teng, M., Xu, C., Qiu, Y., & Cao, J. (2019) · Europe PMC (PubMed Central) · Cited by 15
Yuan, Y., Liu, L., Wang, Y., & Liu, S. (2020) · Cell Biology International · doi:10.1002/cbin.11397 · Cited by 8
RNA-Seq Bayesian Network Exploration of Immune System in Bovine
Behdani, E., Ghaderi‐Zefrehei, M., Rafeie, F., Bakhtiarizadeh, M. R., Roshanfekr, H., & Fayazi, J. (2019) · Iranian Journal of Biotechnology · doi:10.29252/ijb.1748 · Cited by 7
Cited by
Tumor promoting roles of IL-10, TGF-β, IL-4, and IL-35: Its implications in cancer immunotherapy
Mirlekar, B. (2022) · SAGE Open Medicine · doi:10.1177/20503121211069012 · Cited by 258
Peña-Romero, A. C., & Orenes-Piñero, E. (2022) · Cancers · doi:10.3390/cancers14071681 · Cited by 257
Tumor-associated macrophage polarization in the inflammatory tumor microenvironment
Zou, Z., Lin, H., Li, M., & Lin, B. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1103149 · Cited by 100
Metadata
- Authors
- Li, L., Yu, R., Cai, T., Chen, Z., Lan, M., Zou, T., Wang, B., Wang, Q., Zhao, Y., & Cai, Y.
- Venue
- International Immunopharmacology
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 88
- Pages
- 106939
- ISSN
- 1567-5769 (ISSN-L)
- OpenAlex
- W3089234402
- Cited by
- 381
- References
- 147
- FWCI
- 10.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.